FUNDED BY THE EU 
https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaf1115/8436829
⚡ The BEAT PERS-AF trial results are going prime time! Our randomised comparison of Pulsed Field Ablation vs. Radiofrequency Ablation in persistent atrial fibrillation will be presented as Late-Breaking Science at EHRA 2026 in Paris 🇫🇷 📅 13 April | 🕙 10:45–11:45 | 📍 Room 1
🚨 Fresh from hashtag#ESCCongress2025 🚨 Hot Line 8 – BEAT PAROX AF 👉 Watch the interview with the principal investigator to discover what the findings could mean for the future of AF ablation and patient care.
Check out the Method Paper Published in Europace Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial
What a great meeting in Paris with inspiring discussions and fresh perspectives. The BEAT AF Annual & Final Meeting sparked many new ideas with even more scientific papers and patient-focused topics to come. A real highlight was the Stakeholders’ Roundtable, ensuring patient voices and regional insights remain in our focus.
🎙️ Great to hear that BEAT PAROX-AF was featured in detail on @This Week in Cardiology Medscape with John Mandrolas podcast on January 30, 2026 Also available on Spotify or AppleMusic
Patients deserve to understand the research that shapes their care. We are pleased to share the patient-friendly summary of the BEAT PAROX-AF trial. Accessible science is good science.